John A. Hooper
- Molecular Biology
- Immunology top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Hematology top 10%
- Cell Biology
- Co-authors
- Emil L. SmithAllan L. GoldsteinGeraldine H. CohenRobert J. DeLangeGary B. ThurmanRichard S. SchulofMildred C. McDanielUlrich Hämmerling
- Topics
- Immunodeficiency and Autoimmune Disorders (6 papers)Platelet Disorders and Treatments (3 papers)Blood disorders and treatments (3 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryThe Journal of Experimental Medicine
- Partner nations
- United StatesCanadaFinland
In The Last Decade
John A. Hooper
20 papers receiving 775 citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 377
- Immunology 282
- Radiology, Nuclear Medicine and Imaging 128
- Hematology 86
- Cell Biology 75
Countries citing papers authored by John A. Hooper
This map shows the geographic impact of John A. Hooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Hooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Hooper more than expected).
Fields of papers citing papers by John A. Hooper
This network shows the impact of papers produced by John A. Hooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Hooper. The network helps show where John A. Hooper may publish in the future.
Co-authorship network of co-authors of John A. Hooper
This figure shows the co-authorship network connecting the top 25 collaborators of John A. Hooper. A scholar is included among the top collaborators of John A. Hooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Hooper. John A. Hooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 11 | |
| 4 | 33 | |
| 5 | 67 | |
| 6 | Intravenous immunoglobulin in clinical practice | 2 |
| 7 | 17 | |
| 8 | The incidence of HTLV-III/LAV seroconversion and non-A, non-B hepatitis in recipients of plasma products. | 1 |
| 9 | Safety of an intravenous immunoglobulin preparation: lack of seroconversion for human immunodeficiency virus antibodies. | 4 |
| 10 | 11 | |
| 11 | 11 | |
| 12 | 6 | |
| 13 | 44 | |
| 14 | 219 | |
| 15 | 203 | |
| 16 | 13 | |
| 17 | 93 | |
| 18 | 36 | |
| 19 | 88 | |
| 20 | 43 |
About John A. Hooper
John A. Hooper is a scholar working on Immunology, Hematology and Virology, having authored 20 papers that have together received 905 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (6 papers), Platelet Disorders and Treatments (3 papers) and Blood disorders and treatments (3 papers). The work is most often cited by research in Immunology (282 citations), Hematology (86 citations) and Radiology, Nuclear Medicine and Imaging (128 citations). John A. Hooper has collaborated with scholars based in United States, Canada and Finland. Frequent co-authors include Emil L. Smith, Allan L. Goldstein, Geraldine H. Cohen, Robert J. DeLange, Gary B. Thurman, Richard S. Schulof, Mildred C. McDaniel, Ulrich Hämmerling, Margrit P. Scheid and Edward A. Boyse. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.